DHMC Oncologist Heads to Texas
Lebanon — A Dartmouth oncologist who has led research on lung cancer will be the next provost and executive vice president at The University of Texas MD Anderson Cancer Center in Houston.
Ethan Dmitrovsky, the chairman of the department of pharmacology and toxicology at the Geisel School of Medicine, will become leader of MD Anderson’s research and education programs on July 15, according to an MD Anderson news release. He also will be responsible for the Moon Shots Program, an effort to accelerate the pace of converting scientific discoveries into clinical improvements that reduce cancer deaths.
“This is a wonderful and well-earned opportunity for Ethan, who has made a tremendous impact on Dartmouth and the Geisel School of Medicine during his 15 years here,” said Geisel Dean Wiley “Chip” Souba. “As chair of the department of pharmacology and toxicology, Ethan has built a respected and successful program that has contributed much to our world’s understanding of cancer and how we can lessen the burden of this disease.”
Dmitrovsky is a senior adviser for science and technology to the Dartmouth president, holds an American Cancer Society clinical research professorship and is the chairman of the National Cancer Institute’s Board of Scientific Counselors — Clinical Sciences and Epidemiology.
MD Anderson President Ronald DePinho said Dmitrovsky was an “outstanding leader as well as a highly accomplished scientist and lung cancer clinician” who emerged as the top choice among “many excellent candidates.”
“It’s a privilege for me to join this remarkable institution,” Dmitrovsky said in the release. “I thank President DePinho and the search committee for this opportunity. I will give my all to serve the MD Anderson community.”